HyperVue™ Imaging System
K230691 is the FDA 510(k) clearance record for HyperVue™ Imaging System, a class II device, cleared for Spectrawave, Inc. on under FDA product code NQQ (System, Imaging, Optical Coherence Tomography (Oct)). FDA's definition for product code NQQ reads: "This device uses back-reflected light to create two-dimensional images versus back-reflected sound waves as are used in ultrasound imaging". FDA records list 6 510(k) clearances for Spectrawave, Inc., from to . As of , FDA records show no recalls naming K230691.
Clearance record
- Decision date
- Received
- (86 days to decision)
- Product code
- NQQ System, Imaging, Optical Coherence Tomography (Oct)
- Regulation
- 21 CFR 892.1560
- Device class
- Class II
- Review panel
- Radiology
- Applicant
- Spectrawave, Inc. 12 Oak Park Dr., Bedford MA
- 510(k) summary
- Summary PDF
- Third party review
- No
Clearances, product code NQQ
Trailing 12 monthsShow the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 2 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 1 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
